由于多发性硬化症患者在治疗中转换治疗,潜在的药物浪费的成本会增加
Darin T Okuda1,2, Achal Patel3, Robert Schuldt3
1Department of Neurology The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Journal of health economics and outcomes research
|October 31, 2024
概括
对于患有多发性硬化症 (PwMS) 的人来说,切换疾病修饰疗法 (DMT) 是常见的,这导致了大量的药物浪费和患者和保险公司的成本.
科学领域:
- 卫生经济学 卫生经济学
- 药物经济学 药物经济学
- 多发性硬化症的治疗方法
背景情况:
- 未使用的药物有助于医疗保健成本和环境问题.
- 患有多发性硬化症 (PwMS) 的人经常切换疾病修饰疗法 (DMT),导致药物浪费和保险公司和患者的大量费用.
研究的目的:
- 为了估计潜在的药物浪费 (PMW) 的财务影响,PwMS在美国转换口服或自我注射DMT的PwMS.
主要方法:
- 一项回顾性队列研究,使用了MS成年人的索赔数据 (2017-2021年).
- 基于在日历年内切换期间的DMT交叠日供应的定义PMW队列.
- 计算PMW成本作为在切换点之前的DMT的剩余日供应.
主要成果:
- 大约25%的PwMS导致PMW,34-38%的先前DMT可能会被浪费.
- 总的PMW成本在1,489,859美元之间,保险公司支付了大部分费用 (1,450,328美元),PwMS欠74,578.8美元.
- 每人每年的PMW成本平均为846美元,在研究年中保持一致.
结论:
- 在PwMS中频繁切换DMT会导致大量的潜在药物浪费.
- 这种浪费给患者和医疗保险公司带来了巨大的财务负担.
- 减轻DMT切换浪费的策略可以提高医疗保健资源利用率.
相关概念视频
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
87
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
87
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.9K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.9K
Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K


